Lucas Küppers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucas Küppers has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Birgitta Weltermann
Institute of General Practice and Family Medicine, Medical Faculty of the University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany
2 shared publications - Maximilian Scholl
Institute of Movement Therapy and Movement-oriented Prevention and Rehabilitation, Section I, German Sports University Cologne, Cologne, Germany
2 shared publications - Aida Puia
Department of Community Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania
1 shared publication - Ana Luisa Neves
Department of Primary Care and Public Health, Imperial College London, London, UK
1 shared publication Angeli Gawlik
1 shared publication- Angeli Gawlik
Institute of Psychology, Section I: Health and Social Psychology, German Sport University Cologne, Cologne, Germany
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Taylor & Francis in European Journal of General Practice
- Vol. 32 (1) , 2689646
Breast cancer screening in Europe and the role of general practitioners: A 32-country comparative survey
Breast cancer is the commonest cancer in women, and screening can allow earlier-stage diagnosis. While there are European recommendations on the age-range and frequency of breast cancer screening, participation in these programmes varies substantially, and this could be due to differences in how they are organised and implemented. The role that primary healthcare professionals play in the process is unclear.We aimed to describe the breast cancer screening programmes in European countries and investigate how primary healthcare professionals are involved in this screening process. A cross-sectional survey in 32 countries. Key informants with relevant expertise answered online questions about the characteristics of their screening programmes and general practitioners' (GPs') roles in this. Responses were refined through an iterative consensus process. Data were examined to identify patterns in GP engagement. We found important differences between European breast cancer screening systems. While most had population-based screening, four countries relied on opportunistic screening. In 15 countries GPs had little or no involvement in the process of breast cancer screening, and in 13 countries GPs had some involvement, including identifying eligible patients, issuing referrals, and following-up results. Screening uptake rates tended to be higher in countries with well-established population-based screening programmes which give little or no GP involvement. Few countries linked GP engagement to incentives or performance measures. Countries with lower screening uptake should consider either enhancing GP involvement or transitioning to a structured, population-based screening system. Further research should explore how best to integrate primary care within national screening strategies.
- 24 June 2026
- Published by Taylor & Francis in European Journal of General Practice
- Vol. 32 (1) , 2689646
Open AccessBreast cancer screening in Europe and the role of general practitioners: A 32-country comparative survey
Breast cancer is the commonest cancer in women, and screening can allow earlier-stage diagnosis. While there are European recommendations on the age-range and frequency of breast cancer screening, participation in these programmes varies substantially, and this could be due to differences in how they are organised and implemented. The role that primary healthcare professionals play in the process is unclear.We aimed to describe the breast cancer screening programmes in European countries and investigate how primary healthcare professionals are involved in this screening process. A cross-sectional survey in 32 countries. Key informants with relevant expertise answered online questions about the characteristics of their screening programmes and general practitioners' (GPs') roles in this. Responses were refined through an iterative consensus process. Data were examined to identify patterns in GP engagement. We found important differences between European breast cancer screening systems. While most had population-based screening, four countries relied on opportunistic screening. In 15 countries GPs had little or no involvement in the process of breast cancer screening, and in 13 countries GPs had some involvement, including identifying eligible patients, issuing referrals, and following-up results. Screening uptake rates tended to be higher in countries with well-established population-based screening programmes which give little or no GP involvement. Few countries linked GP engagement to incentives or performance measures. Countries with lower screening uptake should consider either enhancing GP involvement or transitioning to a structured, population-based screening system. Further research should explore how best to integrate primary care within national screening strategies.
- Open Access
- 25 March 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e80895
Determinants of the Uptake and Frequency of Use of a Web Portal Digital Health Intervention in Patients With Type 2 Diabetes and/or Coronary Heart Disease: Secondary Analysis of a Randomized Controlled Trial
Background: The targeted application and design of digital health interventions (DHIs) require an understanding of usage determinants. Usage includes uptake (initial use) and frequency (extent of use), but it is unclear whether both components are driven by the same determinants. Objective: This study aimed to examine the determinants of uptake and frequency of use and assess whether they differ. Methods: The investigated DHI was a web portal provided in an intervention for improving disease-related self-management. This study is a secondary analysis of intervention group data from a parallel-group randomized controlled trial. Eligibility criteria were being an adult and being diagnosed with type 2 diabetes and/or coronary heart disease. Sociodemographic, psychological, and health-related variables were examined as determinants. Determinants were analyzed using simple and multiple regression models. Uptake was analyzed using logistic regression, and frequency was analyzed using negative binomial regression with robust SEs. Frequency was analyzed for those who used the DHI at least once. Except for sociodemographic variables, all other variables were standardized to a range from 0 to 1. For simple regression, inflation of the α error due to multiple testing was controlled via the approach of Benjamini and Hochberg, and for multiple regression, it was controlled via the significance of the complete multiple regression model. Results: Of 462 intervention group members, 199 (43.1%) used the web portal at least once. After controlling for inflation of the α error, simple regression for uptake yielded significant effects for higher education (B=0.56, 95% CI 0.18-0.95; P =.004), openness (B=1.08, 95% CI 0.33-1.83; P =.005), intention regarding physical activity (B=2.28, 95% CI 1.30-3.26; P <.001), and intention regarding healthy nutrition (B=2.30, 95% CI 1.30-3.31; P <.001). The multiple regression model for uptake was highly significant ( P <.001), with significant positive associations for intentions regarding physical activity (B=1.86, 95% CI 0.74-2.97; P =.001) and healthy nutrition (B=2.22, 95% CI 1.00-3.44; P <.001), as well as a significant negative association for patient activation (B=−3.20, 95% CI −4.95 to −1.46; P <.001). After controlling for inflation of the α error, simple regression for frequency yielded no statistically significant effect, and the multiple regression model for frequency was not significant ( P =.07). Conclusions: This study is innovative in jointly examining determinants of the uptake and frequency of use of the same DHI within a single context and sample. By demonstrating that factors driving uptake do not necessarily increase the frequency of use, it advances existing research. The study contributes to a more differentiated understanding of DHI use and shows that distinct strategies are required to promote adoption versus sustained engagement. Applying this approach to other DHIs and settings may support more targeted and equitable digital health implementation in real-world contexts, thereby optimizing digital health deployment strategies overall.
- 25 March 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e80895
Open AccessDeterminants of the Uptake and Frequency of Use of a Web Portal Digital Health Intervention in Patients With Type 2 Diabetes and/or Coronary Heart Disease: Secondary Analysis of a Randomized Controlled Trial
Background: The targeted application and design of digital health interventions (DHIs) require an understanding of usage determinants. Usage includes uptake (initial use) and frequency (extent of use), but it is unclear whether both components are driven by the same determinants. Objective: This study aimed to examine the determinants of uptake and frequency of use and assess whether they differ. Methods: The investigated DHI was a web portal provided in an intervention for improving disease-related self-management. This study is a secondary analysis of intervention group data from a parallel-group randomized controlled trial. Eligibility criteria were being an adult and being diagnosed with type 2 diabetes and/or coronary heart disease. Sociodemographic, psychological, and health-related variables were examined as determinants. Determinants were analyzed using simple and multiple regression models. Uptake was analyzed using logistic regression, and frequency was analyzed using negative binomial regression with robust SEs. Frequency was analyzed for those who used the DHI at least once. Except for sociodemographic variables, all other variables were standardized to a range from 0 to 1. For simple regression, inflation of the α error due to multiple testing was controlled via the approach of Benjamini and Hochberg, and for multiple regression, it was controlled via the significance of the complete multiple regression model. Results: Of 462 intervention group members, 199 (43.1%) used the web portal at least once. After controlling for inflation of the α error, simple regression for uptake yielded significant effects for higher education (B=0.56, 95% CI 0.18-0.95; P =.004), openness (B=1.08, 95% CI 0.33-1.83; P =.005), intention regarding physical activity (B=2.28, 95% CI 1.30-3.26; P <.001), and intention regarding healthy nutrition (B=2.30, 95% CI 1.30-3.31; P <.001). The multiple regression model for uptake was highly significant ( P <.001), with significant positive associations for intentions regarding physical activity (B=1.86, 95% CI 0.74-2.97; P =.001) and healthy nutrition (B=2.22, 95% CI 1.00-3.44; P <.001), as well as a significant negative association for patient activation (B=−3.20, 95% CI −4.95 to −1.46; P <.001). After controlling for inflation of the α error, simple regression for frequency yielded no statistically significant effect, and the multiple regression model for frequency was not significant ( P =.07). Conclusions: This study is innovative in jointly examining determinants of the uptake and frequency of use of the same DHI within a single context and sample. By demonstrating that factors driving uptake do not necessarily increase the frequency of use, it advances existing research. The study contributes to a more differentiated understanding of DHI use and shows that distinct strategies are required to promote adoption versus sustained engagement. Applying this approach to other DHIs and settings may support more targeted and equitable digital health implementation in real-world contexts, thereby optimizing digital health deployment strategies overall.
- Open Access
- 18 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Determinants of Digital Health Intervention Use for Patients with Type 2 Diabetes and/or Coronary Heart Disease: Secondary Analysis of a Randomised Controlled Trial (Preprint)
BACKGROUND Digital health interventions (DHIs) can only be effective if they are actually used. Accordingly, appropriate application and/or targeted design of DHIs requires knowledge regarding the determinants of two key aspects of their usage, namely initial “uptake” of the intervention (i.e., use of the DHI at least once), and “frequency” (i.e., how often the DHI is used over time). OBJECTIVE The objective is to investigate the determinants of uptake and frequency in the usage of a specific DHI. METHODS The investigated DHI is part of a complex intervention for improving self-management in persons with type 2 diabetes mellitus and/or coronary heart disease. It consists of a web portal designed to promote physical activity and healthy nutrition among this group. The study presented here is a secondary analysis of data from a randomised controlled trial of this complex intervention (2019-2024). The data was gathered from the 465 members of the intervention group. The variables investigated as possible determinants of DHI use are age, gender, education, the Big Five, loneliness, depression, anxiety, health literacy, patient activation, intention regarding physical activity, and intention regarding healthy nutrition. The relationship with uptake is analysed using logistic regression; the relationship with frequency using Poisson regression with robust standard errors – both for each variable separately (simple regression analysis), and for all variables together (multiple regression analysis). RESULTS For uptake, the simple regression analyses reveal significant positive associations with: higher education (p<.01); openness (p<.01); health literacy (p<.05); and intentions regarding physical activity (p<.001) and healthy nutrition (p<.001). In the multiple regression analysis, only the two intentions remain significant (p<.01 and p<.001), while patient activation (p<.001) emerges as a significant negative predictor. For frequency, the simple regression analyses reveal positive associations with: age (p<.01) and conscientiousness (p<.05); and a negative association with depression (p<.05). In the multiple regression analysis, only age (p<.05) and conscientiousness (p<.05) remain significant, while extraversion (p<.05) and loneliness (p<.05) emerge as significant negative predictors. CONCLUSIONS Individuals who intend to adopt a healthy lifestyle and perceive a need for support are most likely to use the DHI at least once. However, not all addressed individuals use the DHI with equal frequency. Extraverted, less conscientious and lonely people might require different interventions, which should be taken into account when designing complex interventions. CLINICALTRIAL The study was registered in the German Clinical Trials Registry (Deutsches Register Klinischer Studien (DRKS)) in early 2019 under the number 00020592. INTERNATIONAL REGISTERED REPORT RR2-10.1186/s13063-021-05636-4
- 18 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDeterminants of Digital Health Intervention Use for Patients with Type 2 Diabetes and/or Coronary Heart Disease: Secondary Analysis of a Randomised Controlled Trial (Preprint)
BACKGROUND Digital health interventions (DHIs) can only be effective if they are actually used. Accordingly, appropriate application and/or targeted design of DHIs requires knowledge regarding the determinants of two key aspects of their usage, namely initial “uptake” of the intervention (i.e., use of the DHI at least once), and “frequency” (i.e., how often the DHI is used over time). OBJECTIVE The objective is to investigate the determinants of uptake and frequency in the usage of a specific DHI. METHODS The investigated DHI is part of a complex intervention for improving self-management in persons with type 2 diabetes mellitus and/or coronary heart disease. It consists of a web portal designed to promote physical activity and healthy nutrition among this group. The study presented here is a secondary analysis of data from a randomised controlled trial of this complex intervention (2019-2024). The data was gathered from the 465 members of the intervention group. The variables investigated as possible determinants of DHI use are age, gender, education, the Big Five, loneliness, depression, anxiety, health literacy, patient activation, intention regarding physical activity, and intention regarding healthy nutrition. The relationship with uptake is analysed using logistic regression; the relationship with frequency using Poisson regression with robust standard errors – both for each variable separately (simple regression analysis), and for all variables together (multiple regression analysis). RESULTS For uptake, the simple regression analyses reveal significant positive associations with: higher education (p<.01); openness (p<.01); health literacy (p<.05); and intentions regarding physical activity (p<.001) and healthy nutrition (p<.001). In the multiple regression analysis, only the two intentions remain significant (p<.01 and p<.001), while patient activation (p<.001) emerges as a significant negative predictor. For frequency, the simple regression analyses reveal positive associations with: age (p<.01) and conscientiousness (p<.05); and a negative association with depression (p<.05). In the multiple regression analysis, only age (p<.05) and conscientiousness (p<.05) remain significant, while extraversion (p<.05) and loneliness (p<.05) emerge as significant negative predictors. CONCLUSIONS Individuals who intend to adopt a healthy lifestyle and perceive a need for support are most likely to use the DHI at least once. However, not all addressed individuals use the DHI with equal frequency. Extraverted, less conscientious and lonely people might require different interventions, which should be taken into account when designing complex interventions. CLINICALTRIAL The study was registered in the German Clinical Trials Registry (Deutsches Register Klinischer Studien (DRKS)) in early 2019 under the number 00020592. INTERNATIONAL REGISTERED REPORT RR2-10.1186/s13063-021-05636-4
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Short physical performance battery: Pilot study of a human motion capture app (MobiSPPB)
Background: A standardized fall risk assessment can guide targeted interventions. The widely used short physical performance battery (SPPB) for mobility assessment covers balance, gait speed, and lower limb strength, but is time-consuming and requires trained raters. The newly developed video-based smartphone application called MobiSPPB provides a rater-independent SPPB assessment. This study evaluated the technical validity and reliability of the MobiSPPB app compared to the standard rater-based SPPB. In addition, the ability to detect disease-related movement patterns was investigated. Methods: Using a standardized experimental setting, 10 healthy participants performed the SPPB with and without movement impairments simulated by an instant aging suit. Two experienced raters rated the SPPB performance, and a smartphone recorded at the same time. The MobiSPPB app analyzed videos via vision-based human motion capture techniques. Spearman's correlations, the intraclass correlation coefficient (ICC), and receiver operating characteristic curves were calculated. Results: There was a strong correlation between the app and standard SPPB (Spearman's Correlation of 0.869, 95% confidence interval (CI) of 0.79–0.92, p < 0.001). Compared with the standard assessment, the app presented a more significant ICC in the test–retest reliability analysis (0.936, 95% CI of 0.87-0.97, p < 0.001). Detecting disease-related movement patterns achieved high accuracy in capturing severe impairments such as hemiplegia (area under the curve (AUC) 93%). Inconsistencies between the raters indicated that the app provides more objective assessments. Conclusions: The technical validation of the MobiSPPB app was successful in a standardized experimental setting and requires further testing in clinical practice.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessShort physical performance battery: Pilot study of a human motion capture app (MobiSPPB)
Background: A standardized fall risk assessment can guide targeted interventions. The widely used short physical performance battery (SPPB) for mobility assessment covers balance, gait speed, and lower limb strength, but is time-consuming and requires trained raters. The newly developed video-based smartphone application called MobiSPPB provides a rater-independent SPPB assessment. This study evaluated the technical validity and reliability of the MobiSPPB app compared to the standard rater-based SPPB. In addition, the ability to detect disease-related movement patterns was investigated. Methods: Using a standardized experimental setting, 10 healthy participants performed the SPPB with and without movement impairments simulated by an instant aging suit. Two experienced raters rated the SPPB performance, and a smartphone recorded at the same time. The MobiSPPB app analyzed videos via vision-based human motion capture techniques. Spearman's correlations, the intraclass correlation coefficient (ICC), and receiver operating characteristic curves were calculated. Results: There was a strong correlation between the app and standard SPPB (Spearman's Correlation of 0.869, 95% confidence interval (CI) of 0.79–0.92, p < 0.001). Compared with the standard assessment, the app presented a more significant ICC in the test–retest reliability analysis (0.936, 95% CI of 0.87-0.97, p < 0.001). Detecting disease-related movement patterns achieved high accuracy in capturing severe impairments such as hemiplegia (area under the curve (AUC) 93%). Inconsistencies between the raters indicated that the app provides more objective assessments. Conclusions: The technical validation of the MobiSPPB app was successful in a standardized experimental setting and requires further testing in clinical practice.
- Open Access
- 1 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Digital Health Applications (DiGA) for Treating Depression and Generalized Anxiety Disorder: Protocol for a Systematic Health App Review and Systematic Review of Published Evidence (Preprint)
BACKGROUND Depression and generalized anxiety disorder (GAD) are widespread mental health diseases with significant individual and societal consequences. Psychotherapy, particularly cognitive behavioral therapy (CBT), is a common treatment approach, but its application is limited due to costs and staff shortages. Germany has been the first country to integrate and reimburse digital health applications (DiGAs) as an easily accessible treatment option since 2020. Despite regulatory processes, skepticism among physicians regarding clinical relevance and evidence persists. OBJECTIVE This protocol aims to describe the methodology of the planned systematic review. Using expert ratings, the app review will assess the guideline conformity, functions, and usability of German DiGAs for depression and GAD listed at the Federal Institute for Drugs and Medical Devices (BfArM). The additional systematic review will synthesize the effectiveness and quality of these DiGAs based on randomized controlled trials. METHODS The study protocol follows the 2015 PRISMA (Preferred Reporting Items for Systematic Reviews) guideline and was registered in the international Prospective Register of Systematic Reviews (PROSPERO). The review consists of 2 parts: (1) a systematic health app review of DiGAs addressing depression or GAD and (2) a systematic review of published evidence on these DiGAs. The systematic health app review comprises a summary of the DiGA features including the Institute for Healthcare Informatics (IMS) App Functionality Scoring System, a guideline conformity check, and the Mobile Application Rating Scale (MARS) assessment. The systematic review of published evidence is based on a systematic literature search in electronic databases (MEDLINE via PubMed, Cochrane Central Register of Controlled Trials [CENTRAL], Web of Science), as well as relevant websites. The approach includes an effectiveness evaluation, a risk of bias assessment using the Cochrane tool, Risk of Bias 2 (RoB2), and an overall quality evaluation using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method. RESULTS The systematic literature search was conducted in July 2024 and August 2024, and an updated search is planned for November 2025. Data extraction, narrative synthesis, and evaluation of DiGA and corresponding studies are expected to be completed in spring 2026. The results will be presented using a PRISMA flow diagram and tables to display general information, risk of bias, and overall quality. CONCLUSIONS The review will influence both the actual use and future developments of DiGAs. Good quality characteristics will enhance transparency and trust among physicians, while quality deficits provide options for improvement by manufacturers and governing institutions. Consequently, patients’ care with DiGAs may improve. CLINICALTRIAL PROSPERO CRD42024557629; crd.york.ac.uk/PROSPERO/display_record.php?RecordID=557629 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/63380
- 1 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDigital Health Applications (DiGA) for Treating Depression and Generalized Anxiety Disorder: Protocol for a Systematic Health App Review and Systematic Review of Published Evidence (Preprint)
BACKGROUND Depression and generalized anxiety disorder (GAD) are widespread mental health diseases with significant individual and societal consequences. Psychotherapy, particularly cognitive behavioral therapy (CBT), is a common treatment approach, but its application is limited due to costs and staff shortages. Germany has been the first country to integrate and reimburse digital health applications (DiGAs) as an easily accessible treatment option since 2020. Despite regulatory processes, skepticism among physicians regarding clinical relevance and evidence persists. OBJECTIVE This protocol aims to describe the methodology of the planned systematic review. Using expert ratings, the app review will assess the guideline conformity, functions, and usability of German DiGAs for depression and GAD listed at the Federal Institute for Drugs and Medical Devices (BfArM). The additional systematic review will synthesize the effectiveness and quality of these DiGAs based on randomized controlled trials. METHODS The study protocol follows the 2015 PRISMA (Preferred Reporting Items for Systematic Reviews) guideline and was registered in the international Prospective Register of Systematic Reviews (PROSPERO). The review consists of 2 parts: (1) a systematic health app review of DiGAs addressing depression or GAD and (2) a systematic review of published evidence on these DiGAs. The systematic health app review comprises a summary of the DiGA features including the Institute for Healthcare Informatics (IMS) App Functionality Scoring System, a guideline conformity check, and the Mobile Application Rating Scale (MARS) assessment. The systematic review of published evidence is based on a systematic literature search in electronic databases (MEDLINE via PubMed, Cochrane Central Register of Controlled Trials [CENTRAL], Web of Science), as well as relevant websites. The approach includes an effectiveness evaluation, a risk of bias assessment using the Cochrane tool, Risk of Bias 2 (RoB2), and an overall quality evaluation using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method. RESULTS The systematic literature search was conducted in July 2024 and August 2024, and an updated search is planned for November 2025. Data extraction, narrative synthesis, and evaluation of DiGA and corresponding studies are expected to be completed in spring 2026. The results will be presented using a PRISMA flow diagram and tables to display general information, risk of bias, and overall quality. CONCLUSIONS The review will influence both the actual use and future developments of DiGAs. Good quality characteristics will enhance transparency and trust among physicians, while quality deficits provide options for improvement by manufacturers and governing institutions. Consequently, patients’ care with DiGAs may improve. CLINICALTRIAL PROSPERO CRD42024557629; crd.york.ac.uk/PROSPERO/display_record.php?RecordID=557629 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/63380